Equillium (EQ) Operating Income Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 12.69% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 75.16% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -347.04% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 80.62% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 1.27% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 8.65% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,386.07% |
| 10 | Equillium | 279.21 Mn | 218.82 Mn | - | 36.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.75% |
| Dec 31, 2025 | 666.41% |
| Sep 30, 2025 | -573.78% |
| Jun 30, 2025 | -6,128.00% |
| Mar 31, 2025 | -217.81% |
| Dec 31, 2024 | 161.03% |
| Sep 30, 2024 | 81.26% |
| Jun 30, 2024 | 97.22% |
| Mar 31, 2024 | 32.06% |
| Dec 31, 2023 | -256.71% |
| Sep 30, 2023 | 72.63% |
| Jun 30, 2023 | 73.50% |
| Mar 31, 2023 | 89.00% |
| Dec 31, 2022 | 119.66% |
| Sep 30, 2022 | -34.24% |
| Jun 30, 2022 | -53.25% |
| Mar 31, 2022 | -329.32% |
| Dec 31, 2021 | -15.80% |
| Sep 30, 2021 | -51.34% |
| Jun 30, 2021 | -33.78% |
| Mar 31, 2021 | -16.68% |
| Dec 31, 2020 | -17.78% |
| Sep 30, 2020 | -3.04% |
| Jun 30, 2020 | -2.66% |
| Mar 31, 2020 | -17.39% |
| Dec 31, 2019 | -80.18% |
| Sep 30, 2019 | -184.10% |
| Jun 30, 2019 | -472.36% |
| Mar 31, 2019 | -512.15% |